Sunday, 09 August 2020

Lupin launches Tadalafil Tablets

13 February 2019 | News

It is the generic equivalent of Eli Lilly’s Adcirca Tablets 20mg

Pharma major Lupin announced the launch of Tadalafil Tablets USP 20mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Tadalafil Tablets USP 20mg is the generic equivalent of Eli Lilly’s Adcirca Tablets 20mg. It is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.

Tadalafil Tablets, 20mg had annual sales of approximately US$474.3 million in the US (IQVIA MAT December 2018).

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls